Authorised Therapeutic use (Phase IV) Trial participants are having colectomy due to cancer

Placebo-controlled double-blind trial of the analgesic effect and safety of clonidine in patients after major abdominal surgery

EU CTIS ID: 2024-516325-31-01

What this study is testing

The relationship between a single iv. bolus dose of clonidine administered postoperatively to patients undergoing colectomy and postoperative acute pain.

  • Therapeutic use (Phase IV)

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

  • • Planned colectomy due to cancer. • Age over 18 years. • Able to read and understand Danish. • Willingness and able to comply with scheduled visit, treatment plan, laboratory tests and other trial procedures.

You likely can't join if

  • • Sick sinus syndrome. • Second- or third-degree atrioventricular block. • Known hypersensitivity, intolerance or allergy towards clonidine or morphine. • Clinically relevant side effects or symptoms of allergy, judged by the investigator. • Pregnancy (positive urine HCG)/ lactating. • Participants with any clinical abnormalities that, in the opinion of the investigator, may increase the risk associated with trial participation or may interfere with the interpretation of the trial results • Participation in other clinical studies less than six month prior to inclusion. • Hypotension (persistent systolic blood pressure below 100 mmHg). • Bradycardia (< 50 beats/minute). • Known significant decreased kidney function, or an eGFR below 30 ml/min. • Use of a α-agonist drug. (Clonidine, Dexmedetomidine, Tizanidine). • Use of a α-adrenoceptor blocking drug. (Phentolamine, Tolazoline, Phenoxybenzamine, Prazosin, Terazosin, Doxazosin, Alfuzosin, Bunazosin, Tamsulosin, Silodosin, Yohimbine, Idazoxan, Ergot alkaloids).

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.